Market cap
₹2 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-6 Cr
-
ROE
-1.4 %
-
ROCE
-1.3 %
-
Industry P/E
48.59
-
EV/EBITDA
-13.5
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹-0.3
-
Face value
10
-
Shares outstanding
5,209,200
10 Years Aggregate
CFO
₹2.23 Cr
EBITDA
₹-0.57 Cr
Net Profit
₹-2.20 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Trans Asia
| -- | -21.2 | -15.8 | -- | -2.3 | -6.1 | -9.2 |
|
BSE Sensex*
| -12.7 | -4.5 | -4.0 | -9.6 | 3.8 | 4.2 | 9.9 |
|
BSE Healthcare#
| 18.8 | 2.0 | 6.2 | 16.5 | 22.9 | 14.5 | 12.0 |
|
Company
|
2016
|
|---|---|
|
Trans Asia
| -32.4 |
|
BSE Sensex
| 1.9 |
|
BSE Healthcare
| -12.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Trans Asia
|
3.2 | 1.7 | 0.0 | -5.6 | -- | -4.3 | -- | 4.0 |
| 3,272.5 | 26,788.2 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.4 | 15.5 | |
| 863.8 | 16,975.2 | 7,784.0 | 688.5 | 10.6 | 14 | 24.5 | 2.9 | |
| 459.3 | 17,563.1 | 2,141.5 | 58.5 | 5.8 | 3.3 | 165.3 | 4.6 | |
| 868.7 | 23,768.7 | 5,632.3 | 662.4 | 17.2 | 14.3 | 35.9 | 4.8 | |
| 1,072.0 | 17,109.2 | 8,608.3 | 351.6 | 8.7 | 5.7 | 48.6 | 2.4 | |
| 1,602.6 | 18,359.3 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.1 | |
| 210.3 | 27,984.9 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,676.3 | 27,762.2 | 1,935.8 | 288.2 | 20.6 | 29.8 | 96.3 | 20.7 | |
| 2,265.6 | 36,827.2 | 3,564.0 | 414.0 | 15.3 | 8.4 | 90 | 7.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Trans Asia
Trans Asia Corporation Limited engages in the trading of plastic products and other commodities in India. It offers HR, CR, galvanized, and specialty steel products; agro commodities, such as soya deoiled cakes, edible oils, and rape seed cakes;... chemicals, including acetone, IPA, MPG, maleic anhydride, styrene, toluene, and methanol; and PET, LDPE/HDPE, PS, and PP polymers. The company was formerly known as Gujarat Overseas Drugs Limited. Trans Asia Corporation Limited was incorporated in 1993 and is based in Mumbai, India. Read more
-
Incorporated
1993
-
Chairman
Vikram Khandelwal
-
Managing Director
Vikram Khandelwal
-
Headquarters
Indore, Madhya Pradesh
-
Website
FAQs for Trans Asia
What is the current share price of Trans Asia Corporation Ltd Today?
The share price of Trans Asia Corporation Ltd is ₹3.20 (BSE) as of 19-Oct-2021 IST. Trans Asia Corporation Ltd has given a return of -2.35% in the last 3 years.
What is the current PB & PE ratio of Trans Asia Corporation Ltd?
Since, TTM earnings of Trans Asia Corporation Ltd is negative, P/E ratio is not available.
The P/B ratio of Trans Asia Corporation Ltd is 3.98 times as on 19-Oct-2021, a 18 discount to its peers’ median range of 4.85 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2020 |
0.00 |
0.30 |
2019 |
0.00 |
0.29 |
2018 |
0.00 |
0.00 |
2017 |
0.00 |
0.20 |
2016 |
0.00 |
0.28 |
What is the 52 Week High and Low of Trans Asia Corporation Ltd?
The 52-week high and low of Trans Asia Corporation Ltd are Rs -- and Rs -- as of 27-Sep-2026.
What is the market cap of Trans Asia Corporation Ltd?
Trans Asia Corporation Ltd has a market capitalisation of ₹ 2 Cr as on 19-Oct-2021. As per SEBI classification, it is a company.
Should I invest in Trans Asia Corporation Ltd?
Before investing in Trans Asia Corporation Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.